Last updated on July 2017

A Phase 3 Study to Evaluate ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis.


Brief description of study

A Phase 3 Study to Evaluate ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis.

Detailed Study Description

The purpose of this study is to evaluate the efficacy of ADX Ophthalmic Solution on anterior chamber cell count and evaluate the signs and symptoms of ADX-102 Ophthalmic Solution on anterior chamber flare in subjects with non-infectious anterior uveitis.

Clinical Study Identifier: TX13959

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Angela Smit, CCRP

Clinical Eye Research Center of Connecticut
Danbury, CT USA
  Connect »